Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea L Robertson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Infant Behavior & Development|February 28, 2021
Infant effects on experimenter behaviorWallace E Dixon, Lauren P Driggers-Jones, Chelsea L Robertson
Molecular Imaging|January 23, 2014
The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference regionKenji Ishibashi, Chelsea L Robertson, Mark A Mandelkern, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 23, 2016
Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine DependenceKyoji Okita, Nicole Petersen, Chelsea L Robertson, et al.
The International Journal of Neuropsychopharmacology|December 15, 2015
Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent IndividualsKyoji Okita, Dara G Ghahremani, Doris E Payer, et al.
Drug and Alcohol Dependence|February 17, 2016
Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine usersKyoji Okita, Dara G Ghahremani, Doris E Payer, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 23, 2013
Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activityMilky Kohno, Dara G Ghahremani, Angelica M Morales, et al.
The International Journal of Neuropsychopharmacology|January 22, 2015
Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine DependenceMichael E Ballard, Mark A Mandelkern, John R Monterosso, et al.
HGG Advances|December 10, 2025
Viewing direct-to-consumer genetic test results for depression risk is psychologically well tolerated: Evidence from a longitudinal equivalence studyRebecca M K Berns, Devika Dhamija, Daniella Coker, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine UsersScott J Moeller, Kyoji Okita, Chelsea L Robertson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2015
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjectsChelsea L Robertson, Kenji Ishibashi, Mark A Mandelkern, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Infant Behavior & Development|February 28, 2021
Infant effects on experimenter behaviorWallace E Dixon, Lauren P Driggers-Jones, Chelsea L Robertson
Molecular Imaging|January 23, 2014
The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference regionKenji Ishibashi, Chelsea L Robertson, Mark A Mandelkern, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 23, 2016
Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine DependenceKyoji Okita, Nicole Petersen, Chelsea L Robertson, et al.
The International Journal of Neuropsychopharmacology|December 15, 2015
Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent IndividualsKyoji Okita, Dara G Ghahremani, Doris E Payer, et al.
Drug and Alcohol Dependence|February 17, 2016
Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine usersKyoji Okita, Dara G Ghahremani, Doris E Payer, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 23, 2013
Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activityMilky Kohno, Dara G Ghahremani, Angelica M Morales, et al.
The International Journal of Neuropsychopharmacology|January 22, 2015
Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine DependenceMichael E Ballard, Mark A Mandelkern, John R Monterosso, et al.
HGG Advances|December 10, 2025
Viewing direct-to-consumer genetic test results for depression risk is psychologically well tolerated: Evidence from a longitudinal equivalence studyRebecca M K Berns, Devika Dhamija, Daniella Coker, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine UsersScott J Moeller, Kyoji Okita, Chelsea L Robertson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2015
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjectsChelsea L Robertson, Kenji Ishibashi, Mark A Mandelkern, et al.
Pageof 2